Diagnostics News and Research

RSS

Major step forward in using saliva to detect oral cancer

Scientists funded by the National Institute of Dental and Craniofacial Research reported taking a major step forward in using saliva to detect oral cancer.

21 Dec 2004

Messenger RNA not only are measurable in saliva but can indicate a developing tumor

Scientists funded by the National Institute of Dental and Craniofacial Research reported today taking a major step forward in using saliva to detect oral cancer.

20 Dec 2004

Millennium Pharmaceuticals discovers protein biomarkers that could play a role in the early detection of rheumatoid arthritis

Researchers at Millennium Pharmaceuticals today announced the discovery of a panel of protein biomarkers that could play a role in the early detection, prognosis and monitoring of rheumatoid arthritis (RA).

14 Dec 2004

New approach to genomic testing identifies women with low risk of breast cancer recurrence

An initial validation study presented by Exagen Diagnostics at the San Antonio Breast Cancer Symposium suggests it may soon be possible to distinguish good prognosis from poor prognosis in any newly diagnosed breast cancer patient based on DNA changes in the patient's tumor.

13 Dec 2004

Escalating costs and lengthy clinical trials are major concerns for researchers in the field of drug discovery

Escalating costs and lengthy clinical trials are major concerns for researchers attempting to boost productivity and efficiency in the field of drug discovery. Biomarkers are emerging as the solution to these problems with their ability to reduce drug development costs and time.

7 Dec 2004

Electrochemical DNA chip that is able to detect DNA at very low concentrations

Toshiba Corporation has announced the development of a highly sensitive electrochemical DNA chip that is able to detect DNA at very low concentrations, a capability that will support advances in gene detection and analysis for individual treatment regimes, and the monitoring of healthy individuals for any predisposition to certain diseases.

6 Dec 2004

Nanogen issued new patent for active biological sample preparation

Nanogen announced today that it was issued U.S. Patent No. 6,824,740, "Apparatus for Active Biological Sample Preparation," by the U.S. Patent and Trademark Office.

6 Dec 2004

Scientist develops way to deliver promising genetic tool into living cells

By exploiting an HIV protein that readily traverses cell membranes, Carnegie Mellon University scientists have developed a new way to introduce a gene-like molecule called a peptide nucleic acid (PNA) directly into live mammalian cells, including human embryonic stem (ES) cells.

6 Dec 2004

New virtual microscopy system

Researchers at the universities of Helsinki and Tampere (Finland) have developed a new virtual microscopy system, which allows users digitize entire microscope glass slide specimens, and then create a virtual slide with the quality and resolution similar to the original glass slide viewed on a microscope.

29 Nov 2004

Effective research could prevent half of the world's deaths

Health systems research has the potential to produce dramatic improvements in health worldwide and to meet some of the major development challenges in the new millennium.

11 Nov 2004

Research aims to understand how genetic information translates into biological activity

The National Institute of Standards and Technology (NIST) has launched a new $6.25 million, five-year program to explore and address challenges in measurement, validation and quality control for the rapidly growing field of gene expression profiling.

11 Nov 2004

Nanogen announces clinical diagnostic to simultaneously detect multiple respiratory viruses

Nanogen announced today that it is developing new analyte specific reagents (ASRs) for clinical reference laboratories to develop and validate a single test to detect six of the most common respiratory viruses.

10 Nov 2004

Psoriasis trial enters final stage

Solbec Pharmaceuticals Ltd today announced the successful completion of the first two stages of the Phase I clinical trial of its lead compound, CoramsineTM (SBP002), for the treatment of psoriasis.

4 Nov 2004

New non-invasive diagnostic test for early-stage lung cancer

A non-invasive diagnostic test for early-stage bronchial carcinoma (lung cancer) was presented at White Rose Bioscience Forum in York yesterday (03 November).

4 Nov 2004

New vaccines to counter biological agents such as anthrax

Scientists at Imperial College London and Hammersmith Hospital are to help develop new vaccines in case of a terrorist release of biological agents such as anthrax.

1 Nov 2004

New molecular tool to pinpoint DNA mutations among thousands of cells

Scientists have designed a new molecular tool, dubbed "LigAmp," to pinpoint DNA mutations among thousands of cells, the equivalent of searching for a single typo in an entire library of books.

28 Oct 2004

A radical change is needed in the way TB is tackled globally

On the eve of a major international conference on tuberculosis and lung health, the humanitarian medical organisation Médecins Sans Frontières (MSF) warns that millions of individuals in developing countries continue to die from this curable disease.

26 Oct 2004

National Cancer Institute symposium exploring the application of nanotechnology in the diagnosis, treatment and prevention of cancer

The Case Comprehensive Cancer Center, which includes The Cleveland Clinic Taussig Cancer Center and the Ireland Cancer Center at University Hospitals of Cleveland, will sponsor a National Cancer Institute symposium exploring the application of nanotechnology in the diagnosis, treatment and prevention of cancer.

25 Oct 2004

Infectious diseases physicians call for financial incentives for industry

In the midst of the current national shortage of influenza vaccine, the Infectious Diseases Society of America (IDSA) has renewed its call for Congress and the Administration to implement innovative public policy geared toward removing financial disincentives that have caused pharmaceutical companies to leave the vaccine market.

25 Oct 2004

Tabletop DNA test laboratory cuts disease diagnosis down to 30 minutes

British scientists have developed a tabletop DNA test laboratory that can cut the diagnosis of disease and infection from hours to 30 minutes. This new test laboratory will soon begin trials in UK hospitals.

24 Oct 2004